These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 17369892)

  • 1. Effect of nicotine on neuromuscular transmission in mouse motor synapses.
    Balezina OP; Fedorin VV; Gaidukov AE
    Bull Exp Biol Med; 2006 Jul; 142(1):17-21. PubMed ID: 17369892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Etomidate evokes synaptic vesicle exocytosis without increasing miniature endplate potentials frequency at the mice neuromuscular junction.
    Valadão PA; Naves LA; Gomez RS; Guatimosim C
    Neurochem Int; 2013 Nov; 63(6):576-82. PubMed ID: 24044896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Run-down of neuromuscular transmission during repetitive nerve activity by nicotinic antagonists is not due to desensitization of the postsynaptic receptor.
    Hong SJ; Chang CC
    Br J Pharmacol; 1991 Apr; 102(4):817-22. PubMed ID: 1677297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related fragmentation of the motor endplate is not associated with impaired neuromuscular transmission in the mouse diaphragm.
    Willadt S; Nash M; Slater CR
    Sci Rep; 2016 Apr; 6():24849. PubMed ID: 27094316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Neuronal Nicotinic Receptors Inhibits Acetylcholine Release in the Neuromuscular Junction by Increasing Ca
    Zhilyakov N; Arkhipov A; Malomouzh A; Samigullin D
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of myasthenic IgG on miniature end-plate currents in mouse diaphragm.
    Pennefather P; Quastel DM
    Life Sci; 1980 Dec; 27(22):2047-54. PubMed ID: 7207007
    [No Abstract]   [Full Text] [Related]  

  • 7. Prejunctional effects of anticholinesterase drugs at the endplate: mediated by presynaptic acetylcholine receptors or by postsynaptic potassium efflux?
    Hohlfeld R; Sterz R; Peper K
    Pflugers Arch; 1981 Sep; 391(3):213-8. PubMed ID: 6289243
    [No Abstract]   [Full Text] [Related]  

  • 8. The neuromuscular junction: recent developments.
    Bowman WC
    Eur J Anaesthesiol; 1985 Mar; 2(1):59-93. PubMed ID: 2410263
    [No Abstract]   [Full Text] [Related]  

  • 9. The mechanism of choline-mediated inhibition of acetylcholine release in mouse motor synapses.
    Gaydukov AE; Bogacheva PO; Tarasova EO; Balezina OP
    Acta Naturae; 2014 Oct; 6(4):110-5. PubMed ID: 25558401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of carbachol and alpha-bungarotoxin on the frequency of miniature endplate potentials at the frog neuromuscular junction.
    Bukharaeva E; Ipatova T; Nikolsky EE; Vyskocil F
    Exp Physiol; 2000 Mar; 85(2):125-31. PubMed ID: 10751508
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cholinergic regulation of the evoked quantal release at frog neuromuscular junction.
    Nikolsky EE; Vyskocil F; Bukharaeva EA; Samigullin D; Magazanik LG
    J Physiol; 2004 Oct; 560(Pt 1):77-88. PubMed ID: 15254150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. alpha-Bungarotoxin, kappa-bungarotoxin, alpha-cobratoxin and erabutoxin-b do not affect [3H]acetylcholine release from the rat isolated left hemidiaphragm.
    Apel C; Rícný J; Wagner G; Wessler I
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Dec; 352(6):646-52. PubMed ID: 9053737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Dual action of intracellularly released calcium on the quantal mediator secretion].
    Balezina OP; Bukiia AN; Lapteva VI
    Ross Fiziol Zh Im I M Sechenova; 2005 Jan; 91(1):61-70. PubMed ID: 15773581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Production of antiserum to neurotoxin-2 from Naja naja oxiana cobra venom and reaction with the toxin].
    Bortnik AT; Rozanov SI
    Zh Evol Biokhim Fiziol; 1979; 15(5):543-5. PubMed ID: 92118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-receptor interaction at the frog neuromuscular junction.
    Dreyer F; Peper K; Sterz R; Bradley RJ; Müller KD
    Prog Brain Res; 1979; 49():213-23. PubMed ID: 42113
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.
    Silinsky EM
    J Physiol; 2004 Jul; 558(Pt 2):389-401. PubMed ID: 15146054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clumping and oscillations in evoked transmitter release at the frog neuromuscular junction.
    Meiri H; Rahamimoff R
    J Physiol; 1978 May; 278():513-23. PubMed ID: 209172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in presynaptic potentiation and depression in the variation of the potassium component of the endplate current].
    Matiushkin DP; Shabunova IA; Krivoĭ II
    Dokl Akad Nauk SSSR; 1981; 258(3):765-8. PubMed ID: 6265181
    [No Abstract]   [Full Text] [Related]  

  • 19. An analysis of the mechanisms underlying the non-quantal release of acetylcholine at the mouse neuromuscular junction.
    Vyskocil F; Nikolsky E; Edwards C
    Neuroscience; 1983 Jun; 9(2):429-35. PubMed ID: 6308511
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro action of uridine diphosphate glucose (UDPG) on phrenic diaphragm preparations.
    Pastoris O; Dossena M; Raimondo S; Tanzi F
    Farmaco Sci; 1979 Mar; 34(3):211-6. PubMed ID: 527709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.